Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers at the University of Illinois at Chicago (UIC) are warning patients and physicians about using smart pills until research can prove their successfulness.
The best way to solve interoperability issues in healthcare is through the use of application program interfaces (APIs), Pew Charitable Trusts argues in its latest report.
Accountable care organizations are finally achieving real savings for CMS, according to recent figures, with the majority of savings coming from ACOs that have been in the game longer.
In a recent blog post, the Department of Health and Human Services said it’s releasing materials to encourage physicians to take advantage of telemedicine tools in the ongoing effort to stop the opioid epidemic and better help patients who can’t easily access treatment.
Humana and Fitbit are expanding their partnership to allow more than 5 million of the insurer’s members to potentially have access to Fitbit wellness solutions or health coaching.
The American Hospital Association and hospitals participating in the 340B drug program released a new set of principles for ensuring good stewardship of the program.
About 40 percent of physicians are dissatisfied with electronic health record (EHR) design and interoperability, according to a survey conducted by the Physicians Foundation.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.